nodes	percent_of_prediction	percent_of_DWPC	metapath
L-Glutamine—PPAT—Fluorouracil—head and neck cancer	0.686	1	CbGbCtD
L-Glutamine—CAD—Pyrimidine biosynthesis—TYMS—head and neck cancer	0.00856	0.0756	CbGpPWpGaD
L-Glutamine—TGM3—tongue—head and neck cancer	0.00599	0.0372	CbGeAlD
L-Glutamine—PPAT—Fluoropyrimidine Activity—XRCC3—head and neck cancer	0.00529	0.0467	CbGpPWpGaD
L-Glutamine—CAD—Pyrimidine metabolism—DPYD—head and neck cancer	0.00496	0.0438	CbGpPWpGaD
L-Glutamine—TGM4—epithelium—head and neck cancer	0.00446	0.0277	CbGeAlD
L-Glutamine—NADSYN1—Nicotinate metabolism—PTGS2—head and neck cancer	0.00417	0.0368	CbGpPWpGaD
L-Glutamine—TGM3—mouth—head and neck cancer	0.00403	0.025	CbGeAlD
L-Glutamine—PPAT—Fluoropyrimidine Activity—DPYD—head and neck cancer	0.00351	0.031	CbGpPWpGaD
L-Glutamine—Glutathione—GPX1—head and neck cancer	0.00344	0.713	CrCbGaD
L-Glutamine—GATB—mouth—head and neck cancer	0.00338	0.021	CbGeAlD
L-Glutamine—CTPS1—Nucleotide metabolism—DPYD—head and neck cancer	0.00336	0.0297	CbGpPWpGaD
L-Glutamine—PFAS—Purine metabolism—GPX1—head and neck cancer	0.00322	0.0284	CbGpPWpGaD
L-Glutamine—GMPS—Purine metabolism—GPX1—head and neck cancer	0.00322	0.0284	CbGpPWpGaD
L-Glutamine—QARS—hair follicle—head and neck cancer	0.00316	0.0196	CbGeAlD
L-Glutamine—PFAS—Nucleotide metabolism—DPYD—head and neck cancer	0.003	0.0265	CbGpPWpGaD
L-Glutamine—GMPS—Nucleotide metabolism—DPYD—head and neck cancer	0.003	0.0265	CbGpPWpGaD
L-Glutamine—CAD—Pyrimidine metabolism—TYMS—head and neck cancer	0.00283	0.0249	CbGpPWpGaD
L-Glutamine—TGM2—neck—head and neck cancer	0.00269	0.0167	CbGeAlD
L-Glutamine—SLC7A8—tongue—head and neck cancer	0.00263	0.0163	CbGeAlD
L-Glutamine—PPAT—Fluoropyrimidine Activity—SMUG1—head and neck cancer	0.0025	0.0221	CbGpPWpGaD
L-Glutamine—QARS—mouth—head and neck cancer	0.00248	0.0154	CbGeAlD
L-Glutamine—SLC7A8—hair follicle—head and neck cancer	0.00226	0.014	CbGeAlD
L-Glutamine—QARS—neck—head and neck cancer	0.00212	0.0132	CbGeAlD
L-Glutamine—TGM2—Alpha9 beta1 integrin signaling events—VEGFA—head and neck cancer	0.00209	0.0184	CbGpPWpGaD
L-Glutamine—CTPS1—parotid gland—head and neck cancer	0.00206	0.0128	CbGeAlD
L-Glutamine—GFPT2—parotid gland—head and neck cancer	0.00203	0.0126	CbGeAlD
L-Glutamine—PPAT—Fluoropyrimidine Activity—TYMS—head and neck cancer	0.002	0.0177	CbGpPWpGaD
L-Glutamine—CTPS1—saliva-secreting gland—head and neck cancer	0.00198	0.0123	CbGeAlD
L-Glutamine—GLS—connective tissue—head and neck cancer	0.00195	0.0121	CbGeAlD
L-Glutamine—PFAS—saliva-secreting gland—head and neck cancer	0.00194	0.012	CbGeAlD
L-Glutamine—CAD—Nucleotide metabolism—DPYD—head and neck cancer	0.00193	0.017	CbGpPWpGaD
L-Glutamine—TGM2—connective tissue—head and neck cancer	0.00193	0.012	CbGeAlD
L-Glutamine—CTPS1—Nucleotide metabolism—TYMS—head and neck cancer	0.00192	0.0169	CbGpPWpGaD
L-Glutamine—PPAT—Purine metabolism—GPX1—head and neck cancer	0.0019	0.0167	CbGpPWpGaD
L-Glutamine—GLUL—exocrine gland—head and neck cancer	0.00184	0.0114	CbGeAlD
L-Glutamine—TGM2—epithelium—head and neck cancer	0.00183	0.0114	CbGeAlD
L-Glutamine—F13A1—parotid gland—head and neck cancer	0.00182	0.0113	CbGeAlD
L-Glutamine—GMPS—connective tissue—head and neck cancer	0.00182	0.0113	CbGeAlD
L-Glutamine—CTPS1—Nucleotide metabolism—GPX1—head and neck cancer	0.00181	0.016	CbGpPWpGaD
L-Glutamine—TGM3—lymphoid tissue—head and neck cancer	0.0018	0.0112	CbGeAlD
L-Glutamine—SLC7A8—mouth—head and neck cancer	0.00177	0.011	CbGeAlD
L-Glutamine—PPAT—Nucleotide metabolism—DPYD—head and neck cancer	0.00177	0.0156	CbGpPWpGaD
L-Glutamine—GLUL—hair follicle—head and neck cancer	0.00176	0.0109	CbGeAlD
L-Glutamine—F13A1—saliva-secreting gland—head and neck cancer	0.00174	0.0108	CbGeAlD
L-Glutamine—QARS—parotid gland—head and neck cancer	0.00173	0.0107	CbGeAlD
L-Glutamine—SLC38A3—thyroid gland—head and neck cancer	0.00171	0.0106	CbGeAlD
L-Glutamine—GMPS—Nucleotide metabolism—TYMS—head and neck cancer	0.00171	0.0151	CbGpPWpGaD
L-Glutamine—PFAS—Nucleotide metabolism—TYMS—head and neck cancer	0.00171	0.0151	CbGpPWpGaD
L-Glutamine—QARS—saliva-secreting gland—head and neck cancer	0.00166	0.0103	CbGeAlD
L-Glutamine—NADSYN1—lymphoid tissue—head and neck cancer	0.00165	0.0102	CbGeAlD
L-Glutamine—GLS2—lymphoid tissue—head and neck cancer	0.00165	0.0102	CbGeAlD
L-Glutamine—TGM2—trachea—head and neck cancer	0.00162	0.01	CbGeAlD
L-Glutamine—PFAS—Nucleotide metabolism—GPX1—head and neck cancer	0.00162	0.0143	CbGpPWpGaD
L-Glutamine—GMPS—Nucleotide metabolism—GPX1—head and neck cancer	0.00162	0.0143	CbGpPWpGaD
L-Glutamine—F13A1—connective tissue—head and neck cancer	0.0016	0.00993	CbGeAlD
L-Glutamine—CAD—parotid gland—head and neck cancer	0.00159	0.00989	CbGeAlD
L-Glutamine—TGM1—head—head and neck cancer	0.00155	0.00963	CbGeAlD
L-Glutamine—SLC7A8—neck—head and neck cancer	0.00151	0.00939	CbGeAlD
L-Glutamine—GLS2—thyroid gland—head and neck cancer	0.0015	0.0093	CbGeAlD
L-Glutamine—NADSYN1—thyroid gland—head and neck cancer	0.0015	0.0093	CbGeAlD
L-Glutamine—PFAS—trachea—head and neck cancer	0.0015	0.00929	CbGeAlD
L-Glutamine—GFPT2—trachea—head and neck cancer	0.0015	0.00929	CbGeAlD
L-Glutamine—PPAT—parotid gland—head and neck cancer	0.00148	0.00918	CbGeAlD
L-Glutamine—TGM3—head—head and neck cancer	0.00145	0.00902	CbGeAlD
L-Glutamine—GLS—lymphoid tissue—head and neck cancer	0.00143	0.00885	CbGeAlD
L-Glutamine—F13A1—Alpha9 beta1 integrin signaling events—VEGFA—head and neck cancer	0.00141	0.0125	CbGpPWpGaD
L-Glutamine—TGM2—lymphoid tissue—head and neck cancer	0.00141	0.00875	CbGeAlD
L-Glutamine—Glutathione—GSTM1—head and neck cancer	0.00139	0.287	CrCbGaD
L-Glutamine—GLUL—mouth—head and neck cancer	0.00138	0.00855	CbGeAlD
L-Glutamine—CCBL1—thyroid gland—head and neck cancer	0.00138	0.00853	CbGeAlD
L-Glutamine—GATB—thyroid gland—head and neck cancer	0.00138	0.00853	CbGeAlD
L-Glutamine—SLC1A5—parotid gland—head and neck cancer	0.00137	0.0085	CbGeAlD
L-Glutamine—F13A1—trachea—head and neck cancer	0.00134	0.00834	CbGeAlD
L-Glutamine—NADSYN1—head—head and neck cancer	0.00133	0.00825	CbGeAlD
L-Glutamine—GLS2—head—head and neck cancer	0.00133	0.00825	CbGeAlD
L-Glutamine—GMPS—lymphoid tissue—head and neck cancer	0.00133	0.00824	CbGeAlD
L-Glutamine—SLC1A5—saliva-secreting gland—head and neck cancer	0.00131	0.00814	CbGeAlD
L-Glutamine—GFPT2—lymphoid tissue—head and neck cancer	0.0013	0.00809	CbGeAlD
L-Glutamine—GLS—thyroid gland—head and neck cancer	0.0013	0.00804	CbGeAlD
L-Glutamine—TGM2—thyroid gland—head and neck cancer	0.00128	0.00795	CbGeAlD
L-Glutamine—QARS—trachea—head and neck cancer	0.00128	0.00792	CbGeAlD
L-Glutamine—Nail disorder—Fluorouracil—head and neck cancer	0.00125	0.0365	CcSEcCtD
L-Glutamine—CCBL1—head—head and neck cancer	0.00122	0.00757	CbGeAlD
L-Glutamine—GATB—head—head and neck cancer	0.00122	0.00757	CbGeAlD
L-Glutamine—GMPS—thyroid gland—head and neck cancer	0.00121	0.00749	CbGeAlD
L-Glutamine—CTPS1—thyroid gland—head and neck cancer	0.00121	0.00749	CbGeAlD
L-Glutamine—SLC1A5—connective tissue—head and neck cancer	0.00121	0.00748	CbGeAlD
L-Glutamine—GFPT2—thyroid gland—head and neck cancer	0.00119	0.00735	CbGeAlD
L-Glutamine—PFAS—thyroid gland—head and neck cancer	0.00119	0.00735	CbGeAlD
L-Glutamine—GLUL—neck—head and neck cancer	0.00118	0.00731	CbGeAlD
L-Glutamine—ASNS—parotid gland—head and neck cancer	0.00118	0.00729	CbGeAlD
L-Glutamine—F13A1—lymphoid tissue—head and neck cancer	0.00117	0.00726	CbGeAlD
L-Glutamine—GLS—head—head and neck cancer	0.00115	0.00713	CbGeAlD
L-Glutamine—SLC1A5—epithelium—head and neck cancer	0.00114	0.0071	CbGeAlD
L-Glutamine—TGM2—head—head and neck cancer	0.00114	0.00705	CbGeAlD
L-Glutamine—ASNS—saliva-secreting gland—head and neck cancer	0.00113	0.00698	CbGeAlD
L-Glutamine—QARS—lymphoid tissue—head and neck cancer	0.00111	0.0069	CbGeAlD
L-Glutamine—CAD—Nucleotide metabolism—TYMS—head and neck cancer	0.0011	0.00971	CbGpPWpGaD
L-Glutamine—TGM1—lymph node—head and neck cancer	0.00109	0.00674	CbGeAlD
L-Glutamine—CTPS1—head—head and neck cancer	0.00107	0.00664	CbGeAlD
L-Glutamine—GMPS—head—head and neck cancer	0.00107	0.00664	CbGeAlD
L-Glutamine—F13A1—thyroid gland—head and neck cancer	0.00106	0.0066	CbGeAlD
L-Glutamine—PFAS—head—head and neck cancer	0.00105	0.00652	CbGeAlD
L-Glutamine—CAD—Nucleotide metabolism—GPX1—head and neck cancer	0.00104	0.00919	CbGpPWpGaD
L-Glutamine—SLC1A5—trachea—head and neck cancer	0.00101	0.00628	CbGeAlD
L-Glutamine—QARS—thyroid gland—head and neck cancer	0.00101	0.00627	CbGeAlD
L-Glutamine—PPAT—Nucleotide metabolism—TYMS—head and neck cancer	0.00101	0.00888	CbGpPWpGaD
L-Glutamine—Haemorrhoids—Docetaxel—head and neck cancer	0.000996	0.0291	CcSEcCtD
L-Glutamine—TGM2—Thromboxane A2 receptor signaling—EGFR—head and neck cancer	0.000987	0.00871	CbGpPWpGaD
L-Glutamine—TGM2—Beta1 integrin cell surface interactions—VEGFA—head and neck cancer	0.000961	0.00848	CbGpPWpGaD
L-Glutamine—GLUL—parotid gland—head and neck cancer	0.00096	0.00595	CbGeAlD
L-Glutamine—PPAT—Nucleotide metabolism—GPX1—head and neck cancer	0.000953	0.00841	CbGpPWpGaD
L-Glutamine—F13A1—head—head and neck cancer	0.000943	0.00585	CbGeAlD
L-Glutamine—CAD—thyroid gland—head and neck cancer	0.000932	0.00578	CbGeAlD
L-Glutamine—NADSYN1—lymph node—head and neck cancer	0.000931	0.00578	CbGeAlD
L-Glutamine—GLS2—lymph node—head and neck cancer	0.000931	0.00578	CbGeAlD
L-Glutamine—GLUL—saliva-secreting gland—head and neck cancer	0.000919	0.0057	CbGeAlD
L-Glutamine—Nail disorder—Docetaxel—head and neck cancer	0.000903	0.0264	CcSEcCtD
L-Glutamine—SLC16A10—neck—head and neck cancer	0.000899	0.00557	CbGeAlD
L-Glutamine—QARS—head—head and neck cancer	0.000897	0.00556	CbGeAlD
L-Glutamine—SLC1A5—lymphoid tissue—head and neck cancer	0.000881	0.00547	CbGeAlD
L-Glutamine—ASNS—trachea—head and neck cancer	0.000868	0.00539	CbGeAlD
L-Glutamine—CAD—Endothelin Pathways—MAPK1—head and neck cancer	0.000865	0.00764	CbGpPWpGaD
L-Glutamine—PPAT—thyroid gland—head and neck cancer	0.000864	0.00536	CbGeAlD
L-Glutamine—GATB—lymph node—head and neck cancer	0.000854	0.0053	CbGeAlD
L-Glutamine—CCBL1—lymph node—head and neck cancer	0.000854	0.0053	CbGeAlD
L-Glutamine—GLUL—connective tissue—head and neck cancer	0.000845	0.00524	CbGeAlD
L-Glutamine—CTPS1—Metabolism—UROD—head and neck cancer	0.000839	0.0074	CbGpPWpGaD
L-Glutamine—CAD—head—head and neck cancer	0.000827	0.00513	CbGeAlD
L-Glutamine—GLS—lymph node—head and neck cancer	0.000805	0.00499	CbGeAlD
L-Glutamine—GLUL—epithelium—head and neck cancer	0.000802	0.00497	CbGeAlD
L-Glutamine—SLC1A5—thyroid gland—head and neck cancer	0.0008	0.00497	CbGeAlD
L-Glutamine—NADSYN1—Defective AMN causes hereditary megaloblastic anemia 1—PTGS2—head and neck cancer	0.000798	0.00704	CbGpPWpGaD
L-Glutamine—PPAT—head—head and neck cancer	0.000767	0.00476	CbGeAlD
L-Glutamine—GMPS—lymph node—head and neck cancer	0.00075	0.00465	CbGeAlD
L-Glutamine—CTPS1—lymph node—head and neck cancer	0.00075	0.00465	CbGeAlD
L-Glutamine—GMPS—Metabolism—UROD—head and neck cancer	0.000748	0.0066	CbGpPWpGaD
L-Glutamine—PFAS—Metabolism—UROD—head and neck cancer	0.000748	0.0066	CbGpPWpGaD
L-Glutamine—GFPT2—lymph node—head and neck cancer	0.000736	0.00457	CbGeAlD
L-Glutamine—PFAS—lymph node—head and neck cancer	0.000736	0.00457	CbGeAlD
L-Glutamine—SLC16A10—parotid gland—head and neck cancer	0.000732	0.00454	CbGeAlD
L-Glutamine—SLC7A8—thyroid gland—head and neck cancer	0.000721	0.00447	CbGeAlD
L-Glutamine—Rigors—Docetaxel—head and neck cancer	0.000717	0.0209	CcSEcCtD
L-Glutamine—SLC1A5—head—head and neck cancer	0.00071	0.00441	CbGeAlD
L-Glutamine—GLUL—trachea—head and neck cancer	0.000709	0.0044	CbGeAlD
L-Glutamine—Sepsis—Fluorouracil—head and neck cancer	0.000704	0.0206	CcSEcCtD
L-Glutamine—TGM2—Thromboxane A2 receptor signaling—AKT1—head and neck cancer	0.000699	0.00617	CbGpPWpGaD
L-Glutamine—Pancreatitis—Hydroxyurea—head and neck cancer	0.000693	0.0202	CcSEcCtD
L-Glutamine—Depression—Vinblastine—head and neck cancer	0.00069	0.0201	CcSEcCtD
L-Glutamine—ASNS—thyroid gland—head and neck cancer	0.000687	0.00426	CbGeAlD
L-Glutamine—NADSYN1—Metabolism—UROD—head and neck cancer	0.000684	0.00604	CbGpPWpGaD
L-Glutamine—Neuropathy peripheral—Vinblastine—head and neck cancer	0.000678	0.0198	CcSEcCtD
L-Glutamine—PPAT—Fluoropyrimidine Activity—TP53—head and neck cancer	0.000664	0.00586	CbGpPWpGaD
L-Glutamine—F13A1—lymph node—head and neck cancer	0.000661	0.0041	CbGeAlD
L-Glutamine—F13A1—Beta1 integrin cell surface interactions—VEGFA—head and neck cancer	0.000649	0.00573	CbGpPWpGaD
L-Glutamine—SLC7A8—head—head and neck cancer	0.000639	0.00397	CbGeAlD
L-Glutamine—QARS—lymph node—head and neck cancer	0.000628	0.00389	CbGeAlD
L-Glutamine—Neuropathy peripheral—Hydroxyurea—head and neck cancer	0.000618	0.0181	CcSEcCtD
L-Glutamine—GLUL—lymphoid tissue—head and neck cancer	0.000618	0.00383	CbGeAlD
L-Glutamine—Pharyngitis—Vinblastine—head and neck cancer	0.000616	0.018	CcSEcCtD
L-Glutamine—SLC16A10—epithelium—head and neck cancer	0.000611	0.00379	CbGeAlD
L-Glutamine—GLS2—Metabolism—UROD—head and neck cancer	0.000598	0.00528	CbGpPWpGaD
L-Glutamine—CCBL1—Metabolism—UROD—head and neck cancer	0.000598	0.00528	CbGpPWpGaD
L-Glutamine—GLS—Metabolism—UROD—head and neck cancer	0.000598	0.00528	CbGpPWpGaD
L-Glutamine—Injection site reaction—Docetaxel—head and neck cancer	0.000582	0.017	CcSEcCtD
L-Glutamine—SLC1A5—Transmembrane transport of small molecules—ATP7B—head and neck cancer	0.000581	0.00513	CbGpPWpGaD
L-Glutamine—CAD—lymph node—head and neck cancer	0.000579	0.00359	CbGeAlD
L-Glutamine—GLUL—TNF alpha Signaling Pathway—BCL2L1—head and neck cancer	0.000575	0.00507	CbGpPWpGaD
L-Glutamine—GLUL—thyroid gland—head and neck cancer	0.000561	0.00348	CbGeAlD
L-Glutamine—Candida infection—Docetaxel—head and neck cancer	0.000559	0.0163	CcSEcCtD
L-Glutamine—F13A1—Platelet degranulation—VEGFA—head and neck cancer	0.000557	0.00491	CbGpPWpGaD
L-Glutamine—PPAT—lymph node—head and neck cancer	0.000537	0.00333	CbGeAlD
L-Glutamine—F13A1—Response to elevated platelet cytosolic Ca2+—VEGFA—head and neck cancer	0.00053	0.00468	CbGpPWpGaD
L-Glutamine—Angiopathy—Hydroxyurea—head and neck cancer	0.000514	0.015	CcSEcCtD
L-Glutamine—Sepsis—Docetaxel—head and neck cancer	0.000508	0.0148	CcSEcCtD
L-Glutamine—Chills—Hydroxyurea—head and neck cancer	0.000508	0.0148	CcSEcCtD
L-Glutamine—Ill-defined disorder—Vinblastine—head and neck cancer	0.000501	0.0146	CcSEcCtD
L-Glutamine—GLUL—head—head and neck cancer	0.000498	0.00309	CbGeAlD
L-Glutamine—SLC1A5—lymph node—head and neck cancer	0.000497	0.00308	CbGeAlD
L-Glutamine—GFPT2—Metabolism of proteins—GRP—head and neck cancer	0.000496	0.00438	CbGpPWpGaD
L-Glutamine—SLC38A3—Transmembrane transport of small molecules—ATP7B—head and neck cancer	0.000494	0.00436	CbGpPWpGaD
L-Glutamine—Malaise—Vinblastine—head and neck cancer	0.000487	0.0142	CcSEcCtD
L-Glutamine—CAD—Metabolism—UROD—head and neck cancer	0.000482	0.00425	CbGpPWpGaD
L-Glutamine—SLC16A10—lymphoid tissue—head and neck cancer	0.000471	0.00292	CbGeAlD
L-Glutamine—GLUL—TNF alpha Signaling Pathway—CASP8—head and neck cancer	0.00047	0.00415	CbGpPWpGaD
L-Glutamine—Ill-defined disorder—Hydroxyurea—head and neck cancer	0.000457	0.0134	CcSEcCtD
L-Glutamine—Discomfort—Vinblastine—head and neck cancer	0.000455	0.0133	CcSEcCtD
L-Glutamine—SLC7A8—lymph node—head and neck cancer	0.000448	0.00278	CbGeAlD
L-Glutamine—Neuropathy peripheral—Fluorouracil—head and neck cancer	0.000445	0.013	CcSEcCtD
L-Glutamine—Malaise—Hydroxyurea—head and neck cancer	0.000444	0.013	CcSEcCtD
L-Glutamine—PPAT—Metabolism—UROD—head and neck cancer	0.000441	0.00389	CbGpPWpGaD
L-Glutamine—SLC16A10—thyroid gland—head and neck cancer	0.000428	0.00265	CbGeAlD
L-Glutamine—ASNS—lymph node—head and neck cancer	0.000427	0.00265	CbGeAlD
L-Glutamine—Discomfort—Hydroxyurea—head and neck cancer	0.000415	0.0121	CcSEcCtD
L-Glutamine—Rhinitis—Fluorouracil—head and neck cancer	0.000409	0.0119	CcSEcCtD
L-Glutamine—Pharyngitis—Fluorouracil—head and neck cancer	0.000404	0.0118	CcSEcCtD
L-Glutamine—Oedema—Hydroxyurea—head and neck cancer	0.000402	0.0117	CcSEcCtD
L-Glutamine—Infection—Hydroxyurea—head and neck cancer	0.0004	0.0117	CcSEcCtD
L-Glutamine—Dehydration—Docetaxel—head and neck cancer	0.000395	0.0115	CcSEcCtD
L-Glutamine—Pain—Vinblastine—head and neck cancer	0.000377	0.011	CcSEcCtD
L-Glutamine—Constipation—Vinblastine—head and neck cancer	0.000377	0.011	CcSEcCtD
L-Glutamine—QARS—Gene Expression—RARB—head and neck cancer	0.000365	0.00322	CbGpPWpGaD
L-Glutamine—SLC7A8—Transmembrane transport of small molecules—ATP7B—head and neck cancer	0.000365	0.00322	CbGpPWpGaD
L-Glutamine—Feeling abnormal—Vinblastine—head and neck cancer	0.000363	0.0106	CcSEcCtD
L-Glutamine—CAD—Validated targets of C-MYC transcriptional activation—TP53—head and neck cancer	0.000361	0.00319	CbGpPWpGaD
L-Glutamine—Gastrointestinal pain—Vinblastine—head and neck cancer	0.000361	0.0105	CcSEcCtD
L-Glutamine—Abdominal pain—Vinblastine—head and neck cancer	0.000349	0.0102	CcSEcCtD
L-Glutamine—GLUL—lymph node—head and neck cancer	0.000348	0.00216	CbGeAlD
L-Glutamine—CTPS1—Metabolism—NAT2—head and neck cancer	0.000348	0.00307	CbGpPWpGaD
L-Glutamine—Fatigue—Hydroxyurea—head and neck cancer	0.000347	0.0101	CcSEcCtD
L-Glutamine—Pain—Hydroxyurea—head and neck cancer	0.000344	0.01	CcSEcCtD
L-Glutamine—Constipation—Hydroxyurea—head and neck cancer	0.000344	0.01	CcSEcCtD
L-Glutamine—GLUL—Metabolism—UROD—head and neck cancer	0.000343	0.00303	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism—UROD—head and neck cancer	0.000343	0.00303	CbGpPWpGaD
L-Glutamine—QARS—Gene Expression—YAP1—head and neck cancer	0.000332	0.00293	CbGpPWpGaD
L-Glutamine—Feeling abnormal—Hydroxyurea—head and neck cancer	0.000331	0.00968	CcSEcCtD
L-Glutamine—Hypersensitivity—Vinblastine—head and neck cancer	0.000325	0.00949	CcSEcCtD
L-Glutamine—Neuropathy peripheral—Docetaxel—head and neck cancer	0.000321	0.00938	CcSEcCtD
L-Glutamine—Body temperature increased—Hydroxyurea—head and neck cancer	0.000318	0.00928	CcSEcCtD
L-Glutamine—Asthenia—Vinblastine—head and neck cancer	0.000316	0.00924	CcSEcCtD
L-Glutamine—PFAS—Metabolism—NAT2—head and neck cancer	0.00031	0.00274	CbGpPWpGaD
L-Glutamine—GMPS—Metabolism—NAT2—head and neck cancer	0.00031	0.00274	CbGpPWpGaD
L-Glutamine—CTPS1—Metabolism—DPYD—head and neck cancer	0.000305	0.0027	CbGpPWpGaD
L-Glutamine—Chest pain—Fluorouracil—head and neck cancer	0.000302	0.00882	CcSEcCtD
L-Glutamine—Myalgia—Fluorouracil—head and neck cancer	0.000302	0.00882	CcSEcCtD
L-Glutamine—Discomfort—Fluorouracil—head and neck cancer	0.000298	0.00871	CcSEcCtD
L-Glutamine—Hypersensitivity—Hydroxyurea—head and neck cancer	0.000296	0.00865	CcSEcCtD
L-Glutamine—Rhinitis—Docetaxel—head and neck cancer	0.000295	0.00861	CcSEcCtD
L-Glutamine—Pharyngitis—Docetaxel—head and neck cancer	0.000292	0.00852	CcSEcCtD
L-Glutamine—Dizziness—Vinblastine—head and neck cancer	0.000292	0.00852	CcSEcCtD
L-Glutamine—F13A1—Platelet activation, signaling and aggregation—IL2—head and neck cancer	0.000291	0.00256	CbGpPWpGaD
L-Glutamine—Urinary tract disorder—Docetaxel—head and neck cancer	0.00029	0.00848	CcSEcCtD
L-Glutamine—CTPS1—Metabolism—YAP1—head and neck cancer	0.00029	0.00256	CbGpPWpGaD
L-Glutamine—Oedema—Fluorouracil—head and neck cancer	0.00029	0.00845	CcSEcCtD
L-Glutamine—Asthenia—Hydroxyurea—head and neck cancer	0.000289	0.00843	CcSEcCtD
L-Glutamine—Urethral disorder—Docetaxel—head and neck cancer	0.000288	0.00842	CcSEcCtD
L-Glutamine—Infection—Fluorouracil—head and neck cancer	0.000288	0.0084	CcSEcCtD
L-Glutamine—GLUL—TNF alpha Signaling Pathway—MAPK3—head and neck cancer	0.000285	0.00252	CbGpPWpGaD
L-Glutamine—NADSYN1—Metabolism—NAT2—head and neck cancer	0.000284	0.00251	CbGpPWpGaD
L-Glutamine—Vomiting—Vinblastine—head and neck cancer	0.00028	0.00819	CcSEcCtD
L-Glutamine—Headache—Vinblastine—head and neck cancer	0.000276	0.00807	CcSEcCtD
L-Glutamine—GMPS—Metabolism—DPYD—head and neck cancer	0.000272	0.0024	CbGpPWpGaD
L-Glutamine—PFAS—Metabolism—DPYD—head and neck cancer	0.000272	0.0024	CbGpPWpGaD
L-Glutamine—GLUL—TNF alpha Signaling Pathway—MAPK1—head and neck cancer	0.000271	0.0024	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism of proteins—GRP—head and neck cancer	0.000268	0.00236	CbGpPWpGaD
L-Glutamine—Angiopathy—Docetaxel—head and neck cancer	0.000267	0.00779	CcSEcCtD
L-Glutamine—Dizziness—Hydroxyurea—head and neck cancer	0.000266	0.00777	CcSEcCtD
L-Glutamine—SLC16A10—lymph node—head and neck cancer	0.000266	0.00165	CbGeAlD
L-Glutamine—Chills—Docetaxel—head and neck cancer	0.000264	0.00771	CcSEcCtD
L-Glutamine—Musculoskeletal discomfort—Fluorouracil—head and neck cancer	0.000264	0.0077	CcSEcCtD
L-Glutamine—Nausea—Vinblastine—head and neck cancer	0.000262	0.00765	CcSEcCtD
L-Glutamine—Insomnia—Fluorouracil—head and neck cancer	0.000262	0.00765	CcSEcCtD
L-Glutamine—PFAS—Metabolism—YAP1—head and neck cancer	0.000258	0.00228	CbGpPWpGaD
L-Glutamine—GMPS—Metabolism—YAP1—head and neck cancer	0.000258	0.00228	CbGpPWpGaD
L-Glutamine—Mental disorder—Docetaxel—head and neck cancer	0.000258	0.00752	CcSEcCtD
L-Glutamine—Malnutrition—Docetaxel—head and neck cancer	0.000256	0.00748	CcSEcCtD
L-Glutamine—Vomiting—Hydroxyurea—head and neck cancer	0.000256	0.00747	CcSEcCtD
L-Glutamine—GLS—Transmission across Chemical Synapses—MAPK1—head and neck cancer	0.000254	0.00224	CbGpPWpGaD
L-Glutamine—GLS2—Transmission across Chemical Synapses—MAPK1—head and neck cancer	0.000254	0.00224	CbGpPWpGaD
L-Glutamine—Rash—Hydroxyurea—head and neck cancer	0.000254	0.0074	CcSEcCtD
L-Glutamine—Dermatitis—Hydroxyurea—head and neck cancer	0.000253	0.0074	CcSEcCtD
L-Glutamine—Headache—Hydroxyurea—head and neck cancer	0.000252	0.00736	CcSEcCtD
L-Glutamine—NADSYN1—Metabolism—DPYD—head and neck cancer	0.000249	0.0022	CbGpPWpGaD
L-Glutamine—GLS—Metabolism—NAT2—head and neck cancer	0.000248	0.00219	CbGpPWpGaD
L-Glutamine—CCBL1—Metabolism—NAT2—head and neck cancer	0.000248	0.00219	CbGpPWpGaD
L-Glutamine—GLS2—Metabolism—NAT2—head and neck cancer	0.000248	0.00219	CbGpPWpGaD
L-Glutamine—Back pain—Docetaxel—head and neck cancer	0.000248	0.00723	CcSEcCtD
L-Glutamine—Pain—Fluorouracil—head and neck cancer	0.000248	0.00723	CcSEcCtD
L-Glutamine—F13A1—Platelet activation, signaling and aggregation—VEGFA—head and neck cancer	0.000247	0.00218	CbGpPWpGaD
L-Glutamine—Nausea—Hydroxyurea—head and neck cancer	0.000239	0.00698	CcSEcCtD
L-Glutamine—Feeling abnormal—Fluorouracil—head and neck cancer	0.000239	0.00697	CcSEcCtD
L-Glutamine—NADSYN1—Metabolism—YAP1—head and neck cancer	0.000236	0.00209	CbGpPWpGaD
L-Glutamine—F13A1—Platelet activation, signaling and aggregation—MAPK3—head and neck cancer	0.000234	0.00206	CbGpPWpGaD
L-Glutamine—Body temperature increased—Fluorouracil—head and neck cancer	0.000229	0.00668	CcSEcCtD
L-Glutamine—F13A1—Platelet activation, signaling and aggregation—MAPK1—head and neck cancer	0.000222	0.00196	CbGpPWpGaD
L-Glutamine—Myalgia—Docetaxel—head and neck cancer	0.000218	0.00636	CcSEcCtD
L-Glutamine—Chest pain—Docetaxel—head and neck cancer	0.000218	0.00636	CcSEcCtD
L-Glutamine—Arthralgia—Docetaxel—head and neck cancer	0.000218	0.00636	CcSEcCtD
L-Glutamine—GLUL—TNF alpha Signaling Pathway—HRAS—head and neck cancer	0.000218	0.00192	CbGpPWpGaD
L-Glutamine—CCBL1—Metabolism—DPYD—head and neck cancer	0.000218	0.00192	CbGpPWpGaD
L-Glutamine—GLS2—Metabolism—DPYD—head and neck cancer	0.000218	0.00192	CbGpPWpGaD
L-Glutamine—GLS—Metabolism—DPYD—head and neck cancer	0.000218	0.00192	CbGpPWpGaD
L-Glutamine—Hypersensitivity—Fluorouracil—head and neck cancer	0.000213	0.00623	CcSEcCtD
L-Glutamine—Dry mouth—Docetaxel—head and neck cancer	0.000213	0.00622	CcSEcCtD
L-Glutamine—SLC16A10—Transmembrane transport of small molecules—ATP7B—head and neck cancer	0.000212	0.00187	CbGpPWpGaD
L-Glutamine—SLC7A8—Cell surface interactions at the vascular wall—PIK3CA—head and neck cancer	0.000211	0.00186	CbGpPWpGaD
L-Glutamine—Oedema—Docetaxel—head and neck cancer	0.000209	0.0061	CcSEcCtD
L-Glutamine—Infection—Docetaxel—head and neck cancer	0.000208	0.00606	CcSEcCtD
L-Glutamine—CCBL1—Metabolism—YAP1—head and neck cancer	0.000207	0.00182	CbGpPWpGaD
L-Glutamine—GLS—Metabolism—YAP1—head and neck cancer	0.000207	0.00182	CbGpPWpGaD
L-Glutamine—GLS2—Metabolism—YAP1—head and neck cancer	0.000207	0.00182	CbGpPWpGaD
L-Glutamine—Pruritus—Fluorouracil—head and neck cancer	0.000205	0.00598	CcSEcCtD
L-Glutamine—GLS—Transmission across Chemical Synapses—HRAS—head and neck cancer	0.000204	0.0018	CbGpPWpGaD
L-Glutamine—GLS2—Transmission across Chemical Synapses—HRAS—head and neck cancer	0.000204	0.0018	CbGpPWpGaD
L-Glutamine—CAD—Metabolism—NAT2—head and neck cancer	0.0002	0.00177	CbGpPWpGaD
L-Glutamine—SLC7A8—Cell surface interactions at the vascular wall—HRAS—head and neck cancer	0.000195	0.00172	CbGpPWpGaD
L-Glutamine—GLS—Neuronal System—MAPK1—head and neck cancer	0.000195	0.00172	CbGpPWpGaD
L-Glutamine—GLS2—Neuronal System—MAPK1—head and neck cancer	0.000195	0.00172	CbGpPWpGaD
L-Glutamine—F13A1—Platelet activation, signaling and aggregation—PIK3CA—head and neck cancer	0.000193	0.0017	CbGpPWpGaD
L-Glutamine—GLUL—TNF alpha Signaling Pathway—AKT1—head and neck cancer	0.000192	0.0017	CbGpPWpGaD
L-Glutamine—Dizziness—Fluorouracil—head and neck cancer	0.000191	0.00559	CcSEcCtD
L-Glutamine—Musculoskeletal discomfort—Docetaxel—head and neck cancer	0.00019	0.00556	CcSEcCtD
L-Glutamine—Insomnia—Docetaxel—head and neck cancer	0.000189	0.00552	CcSEcCtD
L-Glutamine—Vomiting—Fluorouracil—head and neck cancer	0.000184	0.00537	CcSEcCtD
L-Glutamine—PPAT—Metabolism—NAT2—head and neck cancer	0.000183	0.00162	CbGpPWpGaD
L-Glutamine—Rash—Fluorouracil—head and neck cancer	0.000183	0.00533	CcSEcCtD
L-Glutamine—Dermatitis—Fluorouracil—head and neck cancer	0.000182	0.00533	CcSEcCtD
L-Glutamine—Headache—Fluorouracil—head and neck cancer	0.000181	0.0053	CcSEcCtD
L-Glutamine—Fatigue—Docetaxel—head and neck cancer	0.00018	0.00526	CcSEcCtD
L-Glutamine—Pain—Docetaxel—head and neck cancer	0.000179	0.00522	CcSEcCtD
L-Glutamine—Constipation—Docetaxel—head and neck cancer	0.000179	0.00522	CcSEcCtD
L-Glutamine—CAD—Metabolism—DPYD—head and neck cancer	0.000175	0.00155	CbGpPWpGaD
L-Glutamine—CTPS1—Metabolism—TYMS—head and neck cancer	0.000174	0.00154	CbGpPWpGaD
L-Glutamine—Feeling abnormal—Docetaxel—head and neck cancer	0.000172	0.00503	CcSEcCtD
L-Glutamine—CTPS1—Metabolism—GSTM1—head and neck cancer	0.000172	0.00152	CbGpPWpGaD
L-Glutamine—Nausea—Fluorouracil—head and neck cancer	0.000172	0.00502	CcSEcCtD
L-Glutamine—Gastrointestinal pain—Docetaxel—head and neck cancer	0.000171	0.00499	CcSEcCtD
L-Glutamine—CAD—Metabolism—YAP1—head and neck cancer	0.000166	0.00147	CbGpPWpGaD
L-Glutamine—Abdominal pain—Docetaxel—head and neck cancer	0.000165	0.00482	CcSEcCtD
L-Glutamine—Body temperature increased—Docetaxel—head and neck cancer	0.000165	0.00482	CcSEcCtD
L-Glutamine—CTPS1—Metabolism—GPX1—head and neck cancer	0.000165	0.00145	CbGpPWpGaD
L-Glutamine—CTPS1—Metabolism—CYP1A1—head and neck cancer	0.000163	0.00144	CbGpPWpGaD
L-Glutamine—PPAT—Metabolism—DPYD—head and neck cancer	0.00016	0.00142	CbGpPWpGaD
L-Glutamine—F13A1—Platelet activation, signaling and aggregation—AKT1—head and neck cancer	0.000158	0.00139	CbGpPWpGaD
L-Glutamine—GLS—Neuronal System—HRAS—head and neck cancer	0.000156	0.00138	CbGpPWpGaD
L-Glutamine—GLS2—Neuronal System—HRAS—head and neck cancer	0.000156	0.00138	CbGpPWpGaD
L-Glutamine—GMPS—Metabolism—TYMS—head and neck cancer	0.000155	0.00137	CbGpPWpGaD
L-Glutamine—PFAS—Metabolism—TYMS—head and neck cancer	0.000155	0.00137	CbGpPWpGaD
L-Glutamine—Hypersensitivity—Docetaxel—head and neck cancer	0.000154	0.0045	CcSEcCtD
L-Glutamine—GMPS—Metabolism—GSTM1—head and neck cancer	0.000153	0.00135	CbGpPWpGaD
L-Glutamine—PFAS—Metabolism—GSTM1—head and neck cancer	0.000153	0.00135	CbGpPWpGaD
L-Glutamine—PPAT—Metabolism—YAP1—head and neck cancer	0.000152	0.00134	CbGpPWpGaD
L-Glutamine—Asthenia—Docetaxel—head and neck cancer	0.00015	0.00438	CcSEcCtD
L-Glutamine—F13A1—Hemostasis—IL2—head and neck cancer	0.00015	0.00132	CbGpPWpGaD
L-Glutamine—QARS—Gene Expression—NOTCH1—head and neck cancer	0.00015	0.00132	CbGpPWpGaD
L-Glutamine—Pruritus—Docetaxel—head and neck cancer	0.000148	0.00432	CcSEcCtD
L-Glutamine—PFAS—Metabolism—GPX1—head and neck cancer	0.000147	0.0013	CbGpPWpGaD
L-Glutamine—GMPS—Metabolism—GPX1—head and neck cancer	0.000147	0.0013	CbGpPWpGaD
L-Glutamine—GLUL—Transmission across Chemical Synapses—MAPK1—head and neck cancer	0.000146	0.00129	CbGpPWpGaD
L-Glutamine—PFAS—Metabolism—CYP1A1—head and neck cancer	0.000145	0.00128	CbGpPWpGaD
L-Glutamine—GMPS—Metabolism—CYP1A1—head and neck cancer	0.000145	0.00128	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism—NAT2—head and neck cancer	0.000143	0.00126	CbGpPWpGaD
L-Glutamine—GLUL—Metabolism—NAT2—head and neck cancer	0.000143	0.00126	CbGpPWpGaD
L-Glutamine—NADSYN1—Metabolism—TYMS—head and neck cancer	0.000142	0.00125	CbGpPWpGaD
L-Glutamine—NADSYN1—Metabolism—GSTM1—head and neck cancer	0.00014	0.00124	CbGpPWpGaD
L-Glutamine—Dizziness—Docetaxel—head and neck cancer	0.000138	0.00403	CcSEcCtD
L-Glutamine—NADSYN1—Metabolism—GPX1—head and neck cancer	0.000134	0.00119	CbGpPWpGaD
L-Glutamine—NADSYN1—Metabolism—CYP1A1—head and neck cancer	0.000133	0.00117	CbGpPWpGaD
L-Glutamine—Vomiting—Docetaxel—head and neck cancer	0.000133	0.00388	CcSEcCtD
L-Glutamine—Rash—Docetaxel—head and neck cancer	0.000132	0.00385	CcSEcCtD
L-Glutamine—Dermatitis—Docetaxel—head and neck cancer	0.000132	0.00384	CcSEcCtD
L-Glutamine—Headache—Docetaxel—head and neck cancer	0.000131	0.00382	CcSEcCtD
L-Glutamine—F13A1—Hemostasis—VEGFA—head and neck cancer	0.000127	0.00112	CbGpPWpGaD
L-Glutamine—NADSYN1—Disease—NOTCH1—head and neck cancer	0.000127	0.00112	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism—DPYD—head and neck cancer	0.000125	0.0011	CbGpPWpGaD
L-Glutamine—GLUL—Metabolism—DPYD—head and neck cancer	0.000125	0.0011	CbGpPWpGaD
L-Glutamine—Nausea—Docetaxel—head and neck cancer	0.000124	0.00362	CcSEcCtD
L-Glutamine—GLS2—Metabolism—TYMS—head and neck cancer	0.000124	0.00109	CbGpPWpGaD
L-Glutamine—CCBL1—Metabolism—TYMS—head and neck cancer	0.000124	0.00109	CbGpPWpGaD
L-Glutamine—GLS—Metabolism—TYMS—head and neck cancer	0.000124	0.00109	CbGpPWpGaD
L-Glutamine—CCBL1—Metabolism—GSTM1—head and neck cancer	0.000123	0.00108	CbGpPWpGaD
L-Glutamine—GLS—Metabolism—GSTM1—head and neck cancer	0.000123	0.00108	CbGpPWpGaD
L-Glutamine—GLS2—Metabolism—GSTM1—head and neck cancer	0.000123	0.00108	CbGpPWpGaD
L-Glutamine—F13A1—Hemostasis—MAPK3—head and neck cancer	0.00012	0.00106	CbGpPWpGaD
L-Glutamine—GLUL—Metabolism—YAP1—head and neck cancer	0.000119	0.00105	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism—YAP1—head and neck cancer	0.000119	0.00105	CbGpPWpGaD
L-Glutamine—CCBL1—Metabolism—GPX1—head and neck cancer	0.000117	0.00104	CbGpPWpGaD
L-Glutamine—GLS—Metabolism—GPX1—head and neck cancer	0.000117	0.00104	CbGpPWpGaD
L-Glutamine—GLS2—Metabolism—GPX1—head and neck cancer	0.000117	0.00104	CbGpPWpGaD
L-Glutamine—GLUL—Transmission across Chemical Synapses—HRAS—head and neck cancer	0.000117	0.00103	CbGpPWpGaD
L-Glutamine—GLS—Metabolism—CYP1A1—head and neck cancer	0.000116	0.00103	CbGpPWpGaD
L-Glutamine—CCBL1—Metabolism—CYP1A1—head and neck cancer	0.000116	0.00103	CbGpPWpGaD
L-Glutamine—GLS2—Metabolism—CYP1A1—head and neck cancer	0.000116	0.00103	CbGpPWpGaD
L-Glutamine—F13A1—Hemostasis—MAPK1—head and neck cancer	0.000115	0.00101	CbGpPWpGaD
L-Glutamine—GLUL—Neuronal System—MAPK1—head and neck cancer	0.000112	0.000986	CbGpPWpGaD
L-Glutamine—CCBL1—Disease—NOTCH1—head and neck cancer	0.000111	0.000981	CbGpPWpGaD
L-Glutamine—CAD—Metabolism—TYMS—head and neck cancer	0.0001	0.000882	CbGpPWpGaD
L-Glutamine—F13A1—Hemostasis—PIK3CA—head and neck cancer	9.94e-05	0.000877	CbGpPWpGaD
L-Glutamine—CAD—Metabolism—GSTM1—head and neck cancer	9.88e-05	0.000872	CbGpPWpGaD
L-Glutamine—CTPS1—Metabolism—PTGS2—head and neck cancer	9.7e-05	0.000856	CbGpPWpGaD
L-Glutamine—F13A1—Hemostasis—TP53—head and neck cancer	9.62e-05	0.000849	CbGpPWpGaD
L-Glutamine—CAD—Metabolism—GPX1—head and neck cancer	9.46e-05	0.000835	CbGpPWpGaD
L-Glutamine—NADSYN1—Disease—PTGS2—head and neck cancer	9.44e-05	0.000833	CbGpPWpGaD
L-Glutamine—CAD—Metabolism—CYP1A1—head and neck cancer	9.37e-05	0.000827	CbGpPWpGaD
L-Glutamine—F13A1—Hemostasis—HRAS—head and neck cancer	9.2e-05	0.000812	CbGpPWpGaD
L-Glutamine—PPAT—Metabolism—TYMS—head and neck cancer	9.14e-05	0.000807	CbGpPWpGaD
L-Glutamine—PPAT—Metabolism—GSTM1—head and neck cancer	9.04e-05	0.000798	CbGpPWpGaD
L-Glutamine—GLUL—Neuronal System—HRAS—head and neck cancer	8.97e-05	0.000792	CbGpPWpGaD
L-Glutamine—PPAT—Metabolism—GPX1—head and neck cancer	8.65e-05	0.000764	CbGpPWpGaD
L-Glutamine—GMPS—Metabolism—PTGS2—head and neck cancer	8.64e-05	0.000763	CbGpPWpGaD
L-Glutamine—PFAS—Metabolism—PTGS2—head and neck cancer	8.64e-05	0.000763	CbGpPWpGaD
L-Glutamine—SLC7A8—Hemostasis—IL2—head and neck cancer	8.6e-05	0.000759	CbGpPWpGaD
L-Glutamine—PPAT—Metabolism—CYP1A1—head and neck cancer	8.57e-05	0.000756	CbGpPWpGaD
L-Glutamine—CTPS1—Metabolism—PTEN—head and neck cancer	8.46e-05	0.000747	CbGpPWpGaD
L-Glutamine—QARS—Gene Expression—MAPK3—head and neck cancer	8.28e-05	0.000731	CbGpPWpGaD
L-Glutamine—CCBL1—Disease—PTGS2—head and neck cancer	8.25e-05	0.000728	CbGpPWpGaD
L-Glutamine—NADSYN1—Disease—PTEN—head and neck cancer	8.23e-05	0.000727	CbGpPWpGaD
L-Glutamine—F13A1—Hemostasis—AKT1—head and neck cancer	8.12e-05	0.000717	CbGpPWpGaD
L-Glutamine—NADSYN1—Metabolism—PTGS2—head and neck cancer	7.91e-05	0.000698	CbGpPWpGaD
L-Glutamine—PFAS—Metabolism—PTEN—head and neck cancer	7.54e-05	0.000665	CbGpPWpGaD
L-Glutamine—GMPS—Metabolism—PTEN—head and neck cancer	7.54e-05	0.000665	CbGpPWpGaD
L-Glutamine—NADSYN1—Disease—STAT3—head and neck cancer	7.36e-05	0.00065	CbGpPWpGaD
L-Glutamine—SLC7A8—Hemostasis—VEGFA—head and neck cancer	7.31e-05	0.000645	CbGpPWpGaD
L-Glutamine—CCBL1—Disease—PTEN—head and neck cancer	7.2e-05	0.000635	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism—TYMS—head and neck cancer	7.12e-05	0.000629	CbGpPWpGaD
L-Glutamine—GLUL—Metabolism—TYMS—head and neck cancer	7.12e-05	0.000629	CbGpPWpGaD
L-Glutamine—GLUL—Metabolism—GSTM1—head and neck cancer	7.04e-05	0.000621	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism—GSTM1—head and neck cancer	7.04e-05	0.000621	CbGpPWpGaD
L-Glutamine—NADSYN1—Disease—MAPK3—head and neck cancer	7.03e-05	0.000621	CbGpPWpGaD
L-Glutamine—SLC7A8—Hemostasis—MAPK3—head and neck cancer	6.92e-05	0.00061	CbGpPWpGaD
L-Glutamine—CCBL1—Metabolism—PTGS2—head and neck cancer	6.91e-05	0.00061	CbGpPWpGaD
L-Glutamine—GLS—Metabolism—PTGS2—head and neck cancer	6.91e-05	0.00061	CbGpPWpGaD
L-Glutamine—GLS2—Metabolism—PTGS2—head and neck cancer	6.91e-05	0.00061	CbGpPWpGaD
L-Glutamine—NADSYN1—Metabolism—PTEN—head and neck cancer	6.9e-05	0.000609	CbGpPWpGaD
L-Glutamine—GLUL—Metabolism—GPX1—head and neck cancer	6.74e-05	0.000595	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism—GPX1—head and neck cancer	6.74e-05	0.000595	CbGpPWpGaD
L-Glutamine—NADSYN1—Disease—MAPK1—head and neck cancer	6.69e-05	0.000591	CbGpPWpGaD
L-Glutamine—NADSYN1—Disease—EGFR—head and neck cancer	6.69e-05	0.000591	CbGpPWpGaD
L-Glutamine—GLUL—Metabolism—CYP1A1—head and neck cancer	6.67e-05	0.000589	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism—CYP1A1—head and neck cancer	6.67e-05	0.000589	CbGpPWpGaD
L-Glutamine—SLC7A8—Hemostasis—MAPK1—head and neck cancer	6.58e-05	0.000581	CbGpPWpGaD
L-Glutamine—CCBL1—Disease—STAT3—head and neck cancer	6.44e-05	0.000568	CbGpPWpGaD
L-Glutamine—CCBL1—Disease—MAPK3—head and neck cancer	6.15e-05	0.000543	CbGpPWpGaD
L-Glutamine—GLS—Metabolism—PTEN—head and neck cancer	6.03e-05	0.000532	CbGpPWpGaD
L-Glutamine—CCBL1—Metabolism—PTEN—head and neck cancer	6.03e-05	0.000532	CbGpPWpGaD
L-Glutamine—GLS2—Metabolism—PTEN—head and neck cancer	6.03e-05	0.000532	CbGpPWpGaD
L-Glutamine—CTPS1—Metabolism—PIK3CA—head and neck cancer	5.97e-05	0.000527	CbGpPWpGaD
L-Glutamine—CCBL1—Disease—MAPK1—head and neck cancer	5.85e-05	0.000516	CbGpPWpGaD
L-Glutamine—CCBL1—Disease—EGFR—head and neck cancer	5.85e-05	0.000516	CbGpPWpGaD
L-Glutamine—NADSYN1—Disease—PIK3CA—head and neck cancer	5.81e-05	0.000513	CbGpPWpGaD
L-Glutamine—SLC7A8—Hemostasis—PIK3CA—head and neck cancer	5.71e-05	0.000504	CbGpPWpGaD
L-Glutamine—QARS—Gene Expression—AKT1—head and neck cancer	5.59e-05	0.000493	CbGpPWpGaD
L-Glutamine—CAD—Metabolism—PTGS2—head and neck cancer	5.57e-05	0.000492	CbGpPWpGaD
L-Glutamine—SLC7A8—Hemostasis—TP53—head and neck cancer	5.52e-05	0.000488	CbGpPWpGaD
L-Glutamine—NADSYN1—Disease—HRAS—head and neck cancer	5.37e-05	0.000474	CbGpPWpGaD
L-Glutamine—GMPS—Metabolism—PIK3CA—head and neck cancer	5.32e-05	0.000469	CbGpPWpGaD
L-Glutamine—PFAS—Metabolism—PIK3CA—head and neck cancer	5.32e-05	0.000469	CbGpPWpGaD
L-Glutamine—SLC7A8—Hemostasis—HRAS—head and neck cancer	5.28e-05	0.000466	CbGpPWpGaD
L-Glutamine—PPAT—Metabolism—PTGS2—head and neck cancer	5.09e-05	0.00045	CbGpPWpGaD
L-Glutamine—CCBL1—Disease—PIK3CA—head and neck cancer	5.08e-05	0.000448	CbGpPWpGaD
L-Glutamine—CTPS1—Metabolism—AKT1—head and neck cancer	4.87e-05	0.00043	CbGpPWpGaD
L-Glutamine—NADSYN1—Metabolism—PIK3CA—head and neck cancer	4.86e-05	0.000429	CbGpPWpGaD
L-Glutamine—CAD—Metabolism—PTEN—head and neck cancer	4.86e-05	0.000429	CbGpPWpGaD
L-Glutamine—NADSYN1—Disease—AKT1—head and neck cancer	4.74e-05	0.000419	CbGpPWpGaD
L-Glutamine—CCBL1—Disease—HRAS—head and neck cancer	4.7e-05	0.000415	CbGpPWpGaD
L-Glutamine—SLC7A8—Hemostasis—AKT1—head and neck cancer	4.66e-05	0.000412	CbGpPWpGaD
L-Glutamine—PPAT—Metabolism—PTEN—head and neck cancer	4.44e-05	0.000392	CbGpPWpGaD
L-Glutamine—GMPS—Metabolism—AKT1—head and neck cancer	4.34e-05	0.000383	CbGpPWpGaD
L-Glutamine—PFAS—Metabolism—AKT1—head and neck cancer	4.34e-05	0.000383	CbGpPWpGaD
L-Glutamine—CCBL1—Metabolism—PIK3CA—head and neck cancer	4.25e-05	0.000375	CbGpPWpGaD
L-Glutamine—GLS—Metabolism—PIK3CA—head and neck cancer	4.25e-05	0.000375	CbGpPWpGaD
L-Glutamine—GLS2—Metabolism—PIK3CA—head and neck cancer	4.25e-05	0.000375	CbGpPWpGaD
L-Glutamine—CCBL1—Disease—AKT1—head and neck cancer	4.15e-05	0.000366	CbGpPWpGaD
L-Glutamine—NADSYN1—Metabolism—AKT1—head and neck cancer	3.97e-05	0.000351	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism—PTGS2—head and neck cancer	3.97e-05	0.00035	CbGpPWpGaD
L-Glutamine—GLUL—Metabolism—PTGS2—head and neck cancer	3.97e-05	0.00035	CbGpPWpGaD
L-Glutamine—CCBL1—Metabolism—AKT1—head and neck cancer	3.47e-05	0.000307	CbGpPWpGaD
L-Glutamine—GLS2—Metabolism—AKT1—head and neck cancer	3.47e-05	0.000307	CbGpPWpGaD
L-Glutamine—GLS—Metabolism—AKT1—head and neck cancer	3.47e-05	0.000307	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism—PTEN—head and neck cancer	3.46e-05	0.000306	CbGpPWpGaD
L-Glutamine—GLUL—Metabolism—PTEN—head and neck cancer	3.46e-05	0.000306	CbGpPWpGaD
L-Glutamine—CAD—Metabolism—PIK3CA—head and neck cancer	3.43e-05	0.000302	CbGpPWpGaD
L-Glutamine—PPAT—Metabolism—PIK3CA—head and neck cancer	3.13e-05	0.000277	CbGpPWpGaD
L-Glutamine—CAD—Metabolism—AKT1—head and neck cancer	2.8e-05	0.000247	CbGpPWpGaD
L-Glutamine—PPAT—Metabolism—AKT1—head and neck cancer	2.56e-05	0.000226	CbGpPWpGaD
L-Glutamine—GLUL—Metabolism—PIK3CA—head and neck cancer	2.44e-05	0.000216	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism—PIK3CA—head and neck cancer	2.44e-05	0.000216	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism—AKT1—head and neck cancer	1.99e-05	0.000176	CbGpPWpGaD
L-Glutamine—GLUL—Metabolism—AKT1—head and neck cancer	1.99e-05	0.000176	CbGpPWpGaD
